Top Markets
Coin of the day
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Rang in aandelen #15401
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Aandeelprijs
$9.50
Marktkapitalisatie
$357.67M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
92.70%
Land
US
Handel BioAge Labs Inc. (BIOA)

Categorie

Koersgeschiedenis voor BioAge Labs Inc. (BIOA)
Hoogste slotkoers: $9.50 op 2026-09-01

Laagste slotkoers: $20.04 op 2024-09-01
Koersgeschiedenis van BioAge Labs Inc. van 2024 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 19.87%
2025 48.86%
2024 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$548.98 40.40%
US
$1.03K 44.32%
NL
$121.37 -11.93%
AU
$144.39 499.38%
US
$748.60 4.92%
CH